The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehlert, J. E.
Right arrow Articles by Brandt, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehlert, J. E.
Right arrow Articles by Brandt, E.
The Journal of Immunology, 1998, 161: 4975-4982.
Copyright © 1998 by The American Association of Immunologists

Novel C-Terminally Truncated Isoforms of the CXC Chemokine ß-Thromboglobulin and Their Impact on Neutrophil Functions1

Jan Erik Ehlert2, Johannes Gerdes, Hans-Dieter Flad and Ernst Brandt

Department of Immunology and Cell Biology, Forschungszentrum Borstel, Borstel, Germany

The neutrophil agonist neutrophil-activating peptide-2 (NAP-2) arises through proteolytic processing of platelet-derived N-terminally extended inactive precursors, the most abundant one being connective tissue-activating peptide-III (CTAP-III). Apart from N-terminal processing, C-terminal processing also appears to participate in the functional regulation of NAP-2, as indicated by our recent identification of an isoform missing four C-terminal amino acids, NAP-2 (1–66), which was about threefold more potent than full-size NAP-2. In the present study, we report on the discovery and identification of natural NAP-2 (1–63), an isoform truncated by seven C-terminal residues. Functional and receptor-binding analyses demonstrated that NAP-2 (1–63) represents the most active isoform, being about fivefold more potent than full-size NAP-2. Analyses of rNAP-2 isoforms successively truncated at the C terminus by up to eight residues suggest functionally important roles for acidic residues and for the leucine at position 63, a residue highly conserved within CXC chemokines. Finally, we report on a novel C-terminally truncated isoform of CTAP-III (CTAP-III (1–81)) representing the potential precursor of NAP-2 (1–66). We show that C-terminal truncation in CTAP-III enhances its potency to desensitize chemokine-induced neutrophil activation, indicating that C-terminal processing might not only serve to enhance neutrophil activation, but might as well participate in the down-regulation of an inflammatory response.




This article has been cited by other articles:


Home page
JEMHome page
P. Proost, T. Loos, A. Mortier, E. Schutyser, M. Gouwy, S. Noppen, C. Dillen, I. Ronsse, R. Conings, S. Struyf, et al.
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation
J. Exp. Med., September 1, 2008; 205(9): 2085 - 2097.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Hasan, L. Mazzucchelli, M. Liebi, M. Lis, R. E. Hunger, A. Tester, C. M. Overall, and M. Wolf
Function of Liver Activation-Regulated Chemokine/CC Chemokine Ligand 20 Is Differently Affected by Cathepsin B and Cathepsin D Processing.
J. Immunol., June 1, 2006; 176(11): 6512 - 6522.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. J.J.M. Rennen, C. Frielink, E. Brandt, S. A.J. Zaat, O. C. Boerman, W. J.G. Oyen, and F. H.M. Corstens
Relationship Between Neutrophil-Binding Affinity and Suitability for Infection Imaging: Comparison of 99mTc-Labeled NAP-2 (CXCL-7) and 3 C-Terminally Truncated Isoforms
J. Nucl. Med., July 1, 2004; 45(7): 1217 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Hensbergen, D. Verzijl, C. I. A. Balog, R. Dijkman, R. C. van der Schors, E. M. H. van der Raaij-Helmer, M. J. A. van der Plas, R. Leurs, A. M. Deelder, M. J. Smit, et al.
Furin Is a Chemokine-modifying Enzyme: IN VITRO AND IN VIVO PROCESSING OF CXCL10 GENERATES A C-TERMINALLY TRUNCATED CHEMOKINE RETAINING FULL ACTIVITY
J. Biol. Chem., April 2, 2004; 279(14): 13402 - 13411.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. De La Luz Sierra, F. Yang, M. Narazaki, O. Salvucci, D. Davis, R. Yarchoan, H. H. Zhang, H. Fales, and G. Tosato
Differential processing of stromal-derived factor-1{alpha} and stromal-derived factor-1{beta} explains functional diversity
Blood, April 1, 2004; 103(7): 2452 - 2459.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. I. Schenk, F. Petersen, H.-D. Flad, and E. Brandt
Platelet-Derived Chemokines CXC Chemokine Ligand (CXCL)7, Connective Tissue-Activating Peptide III, and CXCL4 Differentially Affect and Cross-Regulate Neutrophil Adhesion and Transendothelial Migration
J. Immunol., September 1, 2002; 169(5): 2602 - 2610.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. E. Ehlert, A. Ludwig, T. A. Grimm, B. Lindner, H.-D. Flad, and E. Brandt
Down-regulation of neutrophil functions by the ELR+ CXC chemokine platelet basic protein
Blood, November 1, 2000; 96(9): 2965 - 2972.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Wuyts, A. D'Haese, V. Cremers, P. Menten, J.-P. Lenaerts, A. De Loof, H. Heremans, P. Proost, and J. Van Damme
NH2- and COOH-Terminal Truncations of Murine Granulocyte Chemotactic Protein-2 Augment the In Vitro and In Vivo Neutrophil Chemotactic Potency
J. Immunol., December 1, 1999; 163(11): 6155 - 6163.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Stoeckelhuber, P. Dobner, P. Baumgartner, J. Ehlert, E. Brandt, R. Mentele, D. Adam, and B. Engelmann
Stimulation of Cellular Sphingomyelin Import by the Chemokine Connective Tissue-activating Peptide III
J. Biol. Chem., November 22, 2000; 275(48): 37365 - 37372.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.